Related Experiment Video
Updated: Aug 7, 2026

Evaluation of Hepatic Glucose Production in a Polycystic Ovary Syndrome Mouse Model
Published on: March 5, 2022
Early microvascular and macrovascular dysfunction is not accompanied by structural arterial injury in polycystic
Krystallenia Alexandraki1, Athanasios D Protogerou, Theodoros G Papaioannou
1Division of Endocrinology, First Department of Medicine, Laiko Hospital.
Insights
Young women with Polycystic Ovary Syndrome (PCOS) exhibit endothelial dysfunction in large arteries and early microcirculation impairment. These cardiovascular risks are present despite normal blood pressure, glucose, and lipid levels, indicating a need for early intervention in PCOS patients.
Area of Science:
- Cardiovascular Research
- Endocrinology
- Vascular Biology
Background:
- Polycystic Ovary Syndrome (PCOS) is associated with early cardiovascular risk factors and endothelial dysfunction.
- These abnormalities manifest early in life among women diagnosed with PCOS.
Purpose of the Study:
- To conduct a comprehensive assessment of arterial abnormalities in young women with PCOS.
- Utilize non-invasive and reproducible methods to evaluate vascular health in PCOS patients.
Main Methods:
- Compared 27 women with PCOS to 27 age- and BMI-matched controls.
- Assessed macrovascular function via brachial artery flow-mediated dilatation (FMD) and nitrate-induced dilatation (NID).
- Evaluated microvascular function using forearm blood flow and arterial structure through carotid intima-media thickness (IMT).
Main Results:
- Women with PCOS showed significantly lower FMD (3.84%) compared to controls (9.83%).
- No difference in NID was observed, suggesting intact vascular smooth muscle cells.
- Microvascular assessment revealed a longer reactive hyperemia time in PCOS women (20.63 sec vs. 10.38 sec).
- No significant difference in carotid intima-media thickness (IMT) was found between groups.
Conclusions:
- Non-invasive methods revealed endothelial dysfunction in the macrocirculation of young women with PCOS.
- Early microcirculation impairment was demonstrated in PCOS patients with normal metabolic profiles.
- The study highlights subclinical vascular abnormalities in PCOS, independent of traditional cardiovascular risk markers.
Objective:
During the last decade cardiovascular risk factors and endothelial dysfunction have been shown to be present early in life in women with Polycystic Ovary Syndrome (PCOS). The aim of the present study was a global assessment of abnormalities in the arterial bed of young women with PCOS by non-invasive, reproducible methods.
Design:
27 women with PCOS and 27 control women of comparable age, body mass index and waist-to-hip ratio were studied. Macrovascular function was assessed by flow-mediated dilatation (FMD) on the brachial artery. Nitrate-induced dilatation (NID) was performed to exclude a vascular smooth muscle cells injury. Microvascular function was assessed by venous occlusion plethysmography studying forearm blood flow. Arterial structure was evaluated by ultrasonographic assessment of intima-media thickness (IMT) of the carotid artery.
Results:
FMD values were lower in women with PCOS compared to controls (PCOS: 3.84+/-0.74% vs. controls: 9.83+/-0.97%, P<0.001), but no difference was observed in NID (PCOS: 16.59+/-1.84% vs. controls: 16.64+/-2.05%, P=0.98) values. The time required for reactive hyperemia to reach peak value, a plethysmography parameter, was longer in PCOS women (PCOS: 20.63+/-4.67 sec vs. controls: 10.38+/-5.11 sec, P=0.02). No difference was observed in the combined IMT among the studied groups (PCOS: 0.49+/-0.01 mm v.s. controls: 0.51+/-0.02 mm, P=0.19).
Conclusions:
Using non invasive methodologies endothelial dysfunction in the macrocirculation and early impairment in the microcirculation were demonstrated in young women with PCOS who had normal profile of glycemia, lipidemia and blood pressure, and no evidence of structural arterial impairment.
Related Concept Videos
Peripheral Artery Disease I: Introduction
Diabetic Retinopathy
Coronary Artery Disease II: Pathophysiology
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Diabetic Nephropathy
Coronary Artery Disease I: Introduction
